Abciximab dosage and administration

Template:Abciximab Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sheng Shi, M.D. [2], Pratik Bahekar, MBBS [3]

Indications and Usage

Abciximab is indicated as an adjunct to percutaneous coronary intervention for the prevention of cardiac ischemic complications.

• In patients undergoing percutaneous coronary intervention
• In patients with unstable angina not responding to conventional medical therapy when percutaneous coronary intervention is planned within 24 hours

Safety and efficacy of Abciximab use in patients not undergoing percutaneous coronary intervention have not been established.

Abciximab is intended for use with aspirin and heparin and has been studied only in that setting, as described in CLINICAL STUDIES.

References

Adapted from the FDA Package Insert.